drugset / Trial / NCT04975373

Intrauterine Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions

NCT04975373

Unknown 160 enrolled Barzilai Medical Center
RandomizedParallel-groupOpen-labelPrevention

Summary

Women undergoing operative hysteroscopy for removal of retained placenta after delivery will be randomized into two groups. 1. study group - immediately after operative hysteroscopy 5 ml hyaluronic acid gel will be injected into uterine cavity 2. control group - no injection 4-8 weeks after operative hysteroscopy, participants will undergo diagnostic hysteroscopy with no anesthesia , as a part of routine evaluation after removal of retained placenta in Israel. during diagnostic hysteroscopy the uterine cavity will be evaluated and the presence of adhesions and severity of adhesions will be recorded.

Timeline

Start
2021-06-25
Primary completion
2022-07-25
Completion
2022-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified 5 ml Other

Indications